Atlas Trials

Study on the Safety and Efficacy of Convalescent Plasma in Patients With Severe COVID-19 Disease

Clinical trial NCT04542967 · COMPLETED

Trial details

NCT number
NCT04542967
Sponsor
Hospital Central Militar
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe COVID-19 Disease
Start date
2020-06-23
Primary completion
2020-09-02
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.